Outvid vs Dubb for Biotech & Pharma
See how Outvid's AI-powered video outreach compares to Dubb for reaching r&d directors in Biotech & Pharma. Personalized video at scale vs manual recording.
41%
Reduction in time to first substantive conversation
26%
Increase in deal velocity for approved vendors
3x
Higher reply rates vs text-only
Part of the modern revenue stack
Biotech & Pharma sales teams face unique challenges like scientific buyers demand technical credibility upfront. The typical audience — R&D directors, Clinical ops leaders, Pharma procurement — responds best to personalized, relevant outreach via Email and LinkedIn and Medical conferences. In this landscape, the choice between Outvid and Dubb comes down to whether you need scalable AI personalization or manual recording workflows.
How does Outvid compare to Dubb for Biotech & Pharma teams?
| Feature | Outvid | Dubb |
|---|---|---|
Deep per-prospect research written into the script Outvid auto-researches each prospect and writes the script; Dubb leaves the message to you | ||
Pricing model Outvid is credit-based, so cost scales with sending volume; Dubb is per-seat, which gets expensive as the team grows | ||
Multi-step sequences with reply-based branching Both automate follow-up; Outvid branches across four channels on replies, opens, and meetings booked | ||
Personalized video landing pages Both give each prospect a branded landing page; Outvid's is personalized with company intel | ||
Native sending across email, LinkedIn, WhatsApp, and Instagram Outvid sends natively on all four; Dubb centers on video email and SMS with LinkedIn sharing | ||
AI clone that generates video without re-recording With Dubb you record each video yourself (webcam or screen); Outvid generates a unique video per prospect from your AI clone after a one-time 2-minute setup | ||
Screen recording Dubb supports screen and webcam recording for walkthroughs; Outvid focuses on AI-generated outreach video |
Why Biotech & Pharma teams switch to Outvid
No recording, every time
Dubb is built around you hitting record for each message. Outvid records nothing after setup, so your on-camera persona generates a fresh, researched video for every prospect. In Biotech & Pharma, this matters because scientific buyers demand technical credibility upfront.
The agent is the product
Dubb's AI sales agent is a separate subscription bolted onto your video seats. With Outvid the AI SDR is the whole product: research, generation, sending, and follow-up in one place. In Biotech & Pharma, this matters because regulatory complexity slows every decision.
Priced for scale, not per seat
Dubb charges per user, so a growing team pays more just to add people. Outvid's credit pricing scales with how much you send, not headcount. In Biotech & Pharma, this matters because therapeutic area specificity is non-negotiable.
Why is Outvid the better fit for Biotech & Pharma outreach?
Multi-Stakeholder Lab Outreach
Reach the Research Director, VP of Operations, and Procurement Head simultaneously with coordinated video messages tailored to each stakeholder's scientific and operational perspective.
AI clone That Projects Scientific Authority
Record once with your most credible scientific sales professional. Your avatar carries that expertise and gravitas to every prospect interaction, establishing the technical trust that life sciences buyers require before agreeing to a meeting.
Therapeutic Area-Specific Personalization
Generate videos that reference each prospect's disease focus, clinical trial stage, modality, and research infrastructure. A researched, personalized message to an mRNA oncology team looks nothing like one sent to a rare disease biologics group.
Common questions
How does Outvid compare to Dubb for Biotech & Pharma?+
For Biotech & Pharma teams, Outvid offers AI-generated personalized video at scale — each prospect gets a unique video with industry-specific research. Dubb requires manual recording, which limits how many r&d directors you can reach per day.
Why do Biotech & Pharma teams switch from Dubb to Outvid?+
Biotech & Pharma sales teams need to reach r&d directors with messages that reference their specific challenges. Outvid's AI researches each prospect and generates personalized scripts automatically, while Dubb relies on manual effort that doesn't scale.
Can Outvid handle Biotech & Pharma-specific outreach better than Dubb?+
Yes. Outvid enriches each prospect with industry-specific data — company news, hiring signals, funding rounds — and writes scripts that address Biotech & Pharma pain points like scientific buyers demand technical credibility upfront. Dubb leaves this research and scripting to you.
What results do Biotech & Pharma teams see with Outvid vs Dubb?+
Biotech & Pharma teams using Outvid typically see 2-3x higher reply rates compared to text-only outreach or manually recorded videos. The AI personalization means every prospect feels like you spent 10 minutes researching them — even when you've reached hundreds.
Is it easy to switch from Dubb to Outvid for Biotech & Pharma outreach?+
Very easy. Create your AI clone in 2 minutes, import your Biotech & Pharma prospect list, and launch your first campaign in under 15 minutes. No complex migration needed — just a better way to reach r&d directors.
Ready to outperform Dubb in Biotech & Pharma?
Book a 20-minute walkthrough with your prospect data.